Building and promoting Excellence in Life Sciences in Europe
Building and promoting Excellence in Life Sciences in Europe

Instituto Gulbenkian de Ciência

The Instituto Gulbenkian de Ciência (IGC) is an international life science research center in Portugal. Established by the Calouste Gulbenkian Foundation, the IGC's mission is to carry out biomedical research and training. The IGC acts as a host institution to international research groups, providing state-of-the-art research facilities in a stimulating and autonomous environment. The IGC runs several ambitious graduate training programs and a dedicated outreach and public engagement in science program.

Rua da Quinta Grande, 6 P
2780-156 Oeiras
Scientific Director
Instituto Gulbenkian de Ciência
12 Nov 16 Nov 2018

This course will cover basic and advanced flow cytometry topics, with lectures, workshops and practical sessions in multiple systems presented by an incredible panel of experts in the field, such

17 Nov 21 Nov 2017
Ericeira Portugal

About the Workshop

8 Sep 9 Sep 2017
Tomar Portugal

This annual scientific meeting reunites the Portuguese scientific community that uses the Drosophila melanogaster model system, as well as some internationally renowned invited speake

9 Jul 21 Jul 2017
Oeiras Portugal
In the Summer School "Host-microbe symbioses: from functional to ecological perspectives" we will explore stable host-microbe interactions as a spectrum from parasit
30 Nov 3 Dec 2015
Oeiras Portugal

Course description

Implementation of cancer genomics into the clinic is becoming a reality. Personalised medicine or "Precision medicine" as some authors refer to it, uses molecular data from a specific patient to guide clinical decisions such as prevention, diagnosis and treatment. This will revolutionise healthcare and will play a dominant role in the future of cancer therapy. Bioinformatics analyses are essential to identify patients who will benefit from treatment based on their molecular profile, and to tailor chemotherapeutic regimens accordingly.

The aim of this course is to present a complete computational pipeline for the analysis and interpretation of Next-Generation Sequencing (NGS) data, such as exome sequencing or targeted panels that are commonly used in the clinic.

We will address the implementation of large-scale genomic sequencing in clinical practice and recently developed computational strategies for the analysis of NGS data. Particular emphasis will be placed on the interpretation of results, selection of biomarkers for drug responses and affording opportunities to match therapies with the characteristics of individual patient tumours.

Case studies will be used to illustrate the principles of how genetics has influenced the refinement of diagnoses and personalised treatment of cancer disease.

Fátima AlSharhour,
Javier Perales and
Elena Piñeiro.

IMPORTANT DATES for this Course:
Deadline for applications: Nov 16th 2015
Latest notification of acceptance: Nov 17th 2015
Course dates: Nov 30th 2015 to Dec 3rd 2015

TBHD15 Course duration: 4 days TBHD15 Course Fee: Euro 360.00